INE376G01013
INE376G01013
BIOCON LIMITED.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 572.23B EUR | 678.42B EUR | 584.48B EUR | 524.47B EUR |
Enterprise Value | 707.26B EUR | 678.42B EUR | 714.66B EUR | 524.47B EUR |
Valuation Multiples | ||||
Trailing P/E | 103.37x | 136.97x | 151.58x | 201.95x |
Forward P/E | 31.92x | -- | -- | -- |
Price to Sales | 3.3x | 3.94x | 3.47x | 4.25x |
Price to Book | 1.66x | -- | 1.72x | -- |
EV/Revenue | 4.08x | 3.94x | 4.25x | 4.25x |
EV/EBITDA | 19.74x | 17.6x | 18.82x | 19.25x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |